Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to Cerevel Therapeutics First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Related Keywords

Matthew Calistri ,Mohit Bansal ,Graig Suvannavejh ,Paul Matteis ,Jessica Fye ,Mark Bodenrader ,Ray Sanchez ,John Renger ,Michael Yee ,Matt Calistri ,Madhu Kumar ,Charles Duncan ,Tony Coles ,Ron Renaud ,Joseph Thome ,Raymond Sanchez ,Douglas Tsao ,Ceres Inc ,Cerevel Therapeutics Holdings Inc ,Jp Morgan ,Cantor Fitzgerald ,Goldman Sachs ,Wells Fargo ,Idenix Pharmaceuticals ,Nasdaq ,Cerevel Therapeutics Holdings ,Call Transcript May ,Vice President ,Chief Executive Officer ,Chief Medical Officer ,Chief Scientific Officer ,Interim Chief Financial ,Translate Bio ,Tavapadon Phase ,Interim Chief Financial Officer ,Thanks Mark ,Umer Raffat ,